Since the recall of the HeartWare HVAD device in 2021, the management of the remaining
implants range from medical management, transplant, to exchange. This article describes
2 feasible approaches to exchange the HVAD to the HeartMate3 device through a combination
of a left lateral thoracotomy with a superior hemi-sternotomy. These approaches minimize
dissection and complications of a redo-sternotomy and minimizes bypass time. Pitfalls
and solutions are also herein described.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Operative Techniques in Thoracic and Cardiovascular SurgeryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Propensity score-based analysis of long-term follow-up in patients supported with durable centrifugal left ventricular assist devices: The EUROMACS analysis.Eur J Cardiothorac Surg. 2021; 60: 579-587
- Cerebrovascular events in patients with centrifugal-flow left ventricular assist devices: Propensity score-matched analysis from the intermacs registry.Circulation. 2021; 144: 763-772
- Concordance of treatment effect: An analysis of the society of thoracic surgeons intermacs database.Ann Thorac Surg. 2022; 113: 1172-1182
Administration, US Food and Drug. Medtronic Recalls HVAD Pump Implant Kits Due to Delayed or Failed Restart After the Pump is Stopped. [Online] March 01, 2021. Available at: https://www.fda.gov/medical-devices/medical-device-recalls/medtronic-recalls-hvad-pump-implant-kits-due-delayed-or-failed-restart-after-pump-stopped. Accessed April 2022
- HVAD to Heartmate 3 device exchange: A society of thoracic surgeons intermacs analysis.Ann Thorac Surg. 2021; S0003-4975: 01744-01746
- HVAD to HeartMate 3 left ventricular assist device exchange: Best practices recommendations.J Thorac Cardiovasc Surg. 2022; 163: 2120-2127
- Global best practices consensus: Long-term management of patients with hybrid centrifugal flow left ventricular assist device support.J Thorac Cardiovasc Surg. 2022; 164(4): 1120-1137
OPTN. Modify Heart Policy to Address Patient . s.l.: OPTN, 2022.
- HeartMate 3 Left Ventricular Assist System Instruction for Use.United States and Canada Thoratec Corporation, Pleasanton2017
- Exchange of a HeartMate 3 left ventricular assist device through thoracotomy.Oper Tech Thorac Cardiovasc Surg. 2018; 23: 62-75
- Three-year follow-up after less-invasive left ventricular assist device exchange to HeartMate.J Cardiovas Surg. 2021; 62: 646-651
- First series of left ventricular assist device exchanges to HeartMate 3.Eur J Cardiothorac Surg. 2017; 51: 887-892
- Graft resistance difference after HVAD to HeartMate 3 left ventricular assist device exchange.Ann Thorac Surg. 2022; 21: 02170-02176
Article info
Publication history
Published online: October 10, 2022
Publication stage
In Press Journal Pre-ProofFootnotes
Funding: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Conflict of interest: No.
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
ScienceDirect
Access this article on ScienceDirectLinked Article
- Commentary: HeartWare HVAD to HeartMate 3 Device Exchange: Assessing the Technical ChallengesOperative Techniques in Thoracic and Cardiovascular Surgery
